Analysis of subpopulation of T cells showed that CD8+ cells were significantly increased in miR-17 transgenic mice after tumor implantation compared to non-tumor miR-17 mice (27.43% vs. 9.12%, p=0.03). The gene discussed is CD8A; the disease is neoplasm.